ESCRS - FP23.06 - Treatment With 0.75% Phentolamine Ophthalmic Solution Reverses Mydriasis In Healthy Subjects: Results From Mira-2 And Mira-3, Pivotal Phase 3 Clinical Trials

Treatment With 0.75% Phentolamine Ophthalmic Solution Reverses Mydriasis In Healthy Subjects: Results From Mira-2 And Mira-3, Pivotal Phase 3 Clinical Trials

Published 2023 - 41st Congress of the ESCRS

Reference: FP23.06 | Type: Free paper | DOI: 10.82333/jgge-ck21